June | IP NewsLetter -Trademark

June | IP NewsLetter -Trademark

Public comments solicited on the draft amendments to the Measures for the Administration and Protection of Collective Marks and Certification Marks


On 7 June 2022, the China National Intellectual Property Administration (CNIPA) began to solicit public comments on the draft amendments to the Measures for the Administration and Protection of Collective Marks and Certification Marks.


The main modifications are as follows:

1. Modify the name of the regulations to improve the legislative purpose

2. Further standardize the registration application behavior

3. Strengthen the management requirements of the registrant and the user

4. Increase the registration of trademarks containing geographical names and the proper use of provisions

5. Promote the use of trademarks to enhance public services

6. Improve administrative protection to strengthen the penalty measures





Public comments solicited on the Draft Provisions on Prohibition of Abuse of Intellectual Property rights to Exclude and Restrict Competition


On 27 June 2022, the China’s State Administration for Market Regulation (SMAR) released the Draft Provisions on Prohibiting the Abuse of Intellectual Property Rights to Exclude and Restrict Competition and sought public comments. The Draft is meant to implement the revised Anti-Monopoly Law, which comes into force 1 August 2022.


The main modifications are as follows:

1. Modify the name of the regulations;

2. Implement the latest provisions of the revised Anti-Monopoly Law;

3. Improve the anti-monopoly rules in the field of intellectual property rights;

4. Improve the anti-monopoly rules in key areas such as Standard Essential Patents.




Beijing IP Court: Suing others with a trademark not obtained in good faith constitutes an abuse of rights


The Beijing Intellectual Property Court recently upheld a lower court’s decision and ruled that Appellee Shenzhen Chow Tai Fook Online Media Co., Ltd. (“Chow Tai Fook”) and Defendant Beijing Jingdong Century Commerce Co., Ltd. (“Beijing Jingdong”) did not infringe Appellant/Plaintiff Ma Moumou’s trademark because Ma’s action of suing Chow Tai Fook with a trademark not registered in good faith constituted an abuse of rights.


The brand “骄人” (pronounced jiao ren) was created by Chow Tai Fook in 2006 for use on jewelery. Through extensive use and publicity, the brand has enjoyed high reputation. In 2008, Ma applied to register the mark “jiaoren骄人” (Chow Tai Fook’s brand “骄人” with English transliteration added) on jewelry products in Class 14. Ma has not put his mark into acutal commercial use and he has also applied to register more than 30 trademarks, many of which were similar to other parties’ famous trademarks. Ma’s action constitutes trademark hoarding.


In previous effective civil judgment between Ma and Chow Tai Fook’s offline jewelry store, the court held that Chow Tai Fook had a prior right to use the brand “骄人” before Ma’s registration and dismissed Ma’s claims. Ma sued Chow Tai Fook’s online stores in a similar way in this case. Ma has violated the principle of good faith and his action of suing Chow Tai Fook with a trademark not registered in good faith constituted an abuse of rights.



  • Related information More
  • 点击次数: 1000006
    2023 - 12 - 27
    Author:Miao QuMingdun Made a Speech on the Dilemma of Applying the Crime of Concealing the Proceeds of Crime to Diverted Drug CasesOn December 23, 2023, four lawyers from Mingdun Law Firm, including Liu Jinzhu, Zhang Lin, Wang Hui, and Qu Miao, participated in the Second Seminar on the Theory and Practice of Governance of New Types of Crimes as representatives of the members of Beijing Criminology Research Society.This seminar was organized by the Beijing Criminology Research Society, with the theme of "Exploring the Crime Governance System in the New Era and Serving the Rule of Law in the Capital". Superiors from the Supreme Prosecutor's Office, the Supreme Court, the People's Public Security University of China, the Chinese Society of Criminology and other relevant...
  • 点击次数: 1000007
    2023 - 10 - 17
    In September 2022, an insurance company sued our client, an insurance brokerage company as well as a technology company, requiring them to pay the premium collection and claim settlement amount of RMB 3 million.After accepting the entrustment, MingDun patiently listened to the client's briefing on the contract's signing, performance and dispute. Further, our firm carefully reviews the evidence materials of the case, deeply analyzes the evidence materials related to the litigation request, and works with the client to formulate response strategies and actively respond to the litigation. Ultimately, we drafted and submitted a reply and cross-examination opinion to the people's court, but did not participate in the trial.In July 2023, the court ruled that the plaintiff's claim...
  • 点击次数: 1000006
    2023 - 09 - 13
    Recently, MingDun helped our client Novo Nordisk knock out infringing domain names and in Hong Kong. Mingdun successfully prevented the infringer from illegally using Novo Nordisk's goodwill to deceive patients.Our client Novo Nordisk is a world-leading biopharmaceutical company dedicated to human health for the benefit of patients and society with advanced biotechnology. Novo Nordisk's history dates to 1923, and for a hundred years, it has been committed to innovation and lead the field of diabetes. This tradition also gives Novo the experience and ability to help people overcome other serious chronic diseases, such as hemophilia, growth hormone disorders and obesity. Novo Nordisk has about 43,200 employees in 80 countries and regions and provides products and services to more t...
  • 点击次数: 1000008
    2023 - 09 - 11
    Recently, the Market Supervision Administration of Jiujiang City, Jiangxi Province, at the request of MingDun, imposed a fine of CNY 120,000 on the Jiujiang Fuzeyuan Pharmacy for its retail of only 3 boxes of medicines purchased through illegal channels. This case was published as a typical case by Jiangxi Provincial Market Supervision Administration. Details of the case are as follows.In October 2022, MingDun found that the client’s products sold by the Fuzeyuan Pharmacy had actually flowed through the Affiliated Hospital of Jiujiang Medical College. In another word, the client’s products should be at the hand of the patients, and the Fuzeyuan Pharmacy should have purchased the client’s products from illegal channels. The Fuzeyuan Pharmacy should be retailing Diverted Medicine.Under norma...
× WeChat official account
Beijing Mingdun Law Firm
Copyright 2008 - 2020 Beijing Mingdun Law FirmRhino Cloud Provides Enterprise Cloud Services